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In this paper, we empirically study the impact of per capita income on health care 
expenditure and its dynamics over time in a sample of fourteen OECD countries for the 
period 1971 to 2009. A simple model, built upon one developed by Newhouse (1977), 
suggests that health care is a necessity in the short-run but it cannot be rejected to be a 
luxury good in the long-run. Our findings provide strong empirical evidence that a 
year’s health expenditure is conditioned by the previous one. Interestingly, our results 
reveal increasing income inelasticity over time along with huge heterogeneity across 
countries. Finally, this paper supports the hypothesis of conditional convergence in 
health care spending among countries. In designing policies which facilitate the 
sustainability of national health systems, we emphasize that ceteris paribus the greater 
the participation of public health, the lower the growth rate of health spending. 
Meanwhile, high share of children and elderly over working age population opposite 
influences. We also provide evidence that technological progress could reduce the long-
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I. Introduction  
 
How much did improving income rise health care? Since Grossman (1972), there has 
been huge theoretical literature on health as a form of capital stock. So, the correlation 
between economic performance and health is one of the best-known relations in 
international development. Higher per capita income gives citizens greater access over 
many of the goods and services that promote health: nutrition, medicines, schooling, 
and good quality health services (Bloom and Canning, 2000). In this paper, we 
empirically examine the effects of income on health care spending for a sample of 
fourteen OECD countries, and its dynamics over 1971-2009. 
Our research is closely related to a number of theoretical and empirical papers. 
On the theoretical side, our paper is closest in spirit to Newhouse (1977) seminal paper 
that high levels and growth rates of health spending may be justified by income growth. 
Our paper is also related to Newhouse (1992), which provides a survey of possible 
explanations for the rise of health spending as a share of Gross Domestic Product. In 
addition to rise in per capita income, he considers explanation driven by demographic 
changes and changes in national health policies, although Newhouse argues the bulk of 
the increase is attributable to technological change. This explanation has received 
growing attention through the last decade from health economists; for example, Jones 
(2004), and Hall and Jones (2007).  
With respect to the empirical evidence, the open debate over the last few years 
pointed to the size of income elasticity over health expenditure, and whether it is greater 
or less than unit (Bac and Le Pen, 2002). In this regard, it should be noted from Table 1 
that most studies obtained income elasticity of demand for health care around 1.1-1.4 or 
even more. Besides Newhouse’s (1977) seminal paper, for example: Leu (1986), Parkin 
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et al. (1987), Gerdtham et al. (1992a, b), Hitiris (1997), Roberts (2000), Mehrara et al. 
(2010), Liu et al. (2011), Hui-Kuang et al. (2011) and Woodward and Wang (2012). 
However, Gerdtham et al. (1998) estimated coefficients around 0.2-0.9, as was also 
found by Sen (2005), Chakroun (2010), Baltagi and Moscone (2010) and Farag et al. 
(2012).  
[Insert Table 1] 
Furthermore, there is a bulky of papers focused on the evolution of health care 
systems, based on several approaches, i.e.: intrastate or international comparisons 
studies, on time series or on the neoclassical growth theory, etc. Hence, Nixon (1999) 
supports the existence of both convergence and integration of health care expenditure in 
the European Union (UE) countries. Kerem et al. (2008) indicate that —although the 
increase of economic integration facilitates economic growth— the mere fact of the EU 
enlargement does not bring along an automatic homogenization of health care 
expenditure. Wang (2009) obtains moderate evidence of convergence in total health 
care expenditure —and diverse performance of the expenditure components— across 
the US states. Finally, Leither and Theurl (2012) find that OECD countries do not move 
towards a common mean and the rate of convergence is decreasing over time. 
Additionally, rising trends in health expenditure and explanations for health care 
expenditures growth differences across countries (Barros, 1998) during the last four 
decades had concerned about the sustainability of national health care systems 
(Pammolli et al., 2008). This topic had become intriguing to economic researchers, and 
so a growing literature has recently emerged (Chakroun, 2010; Bilgel and Tran, 2013; 
Kumar, 2013). 
We build on this literature in three ways. First, the focus of our paper is on 
understanding the determinants of per capita level of health care expenditure. The 
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abovementioned studies hardly distinguish between short- and long-term, nor take into 
account income clusters of countries and the differences in time. In this paper, our main 
goal will be testing for differences between short-run and long-run income elasticity, 
when controlling for demographic structure, the percentage of public health care 
expenditure over the total and technological change. A simple empirical model, built 
upon one developed by Newhouse (1977), provides a straightforward method for testing 
of on hypotheses derived from economic theory. According to a generally accepted rule, 
income elasticity less than unit classify health expenditure as a “necessary” good. 
Similarly, if elasticity is higher than unit health care will be classified as a “luxury” 
good. Second, we then specify a new model by allowing for health spending 
convergence across countries, based on the neoclassical growth theory (Barro and Sala-
i-Martin, 1995). Third, afterwards the paper carries out diverse sensibility tests, looking 
at differences between subgroups of countries and subperiods of time.  
When estimating the effects of income on health care spending for the period 
1971 to 2009, we adopt the panel data approach. We first assume a linear and 
homogeneous relationship between the variables. Nonetheless, in a second stage, we 
also use a dynamic panel data model by applying the improved Generalized Method of 
Moments (GMM) by Arellano and Bover (1995) and Blundell and Bond (1998). For 
studying the income elasticity of health care dynamics, the full sample is split into two 
subperiods: the initial period (1971-1990) and the subsequent period (1991-2009). 
Furthermore, we divided the full sample of countries into two subgroups based on a 
cluster analysis for the initial observations of health care expenditure and income (that 
is, for year 1971). We find that health care is a necessity in the short-run, though it 
cannot be rejected being a luxury good in the long-run. Estimates indicate that, on 
average, the long-term elasticity for initial low- health expenditure and income country 
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is up to 40% less than other high one. Similarly, about 80% of a year’s health 
expenditure is conditioned by the previous one. Whereas, our findings put forward 
decreasing trends for the elasticity in the time period analysed, and support the 
hypothesis of conditional convergence. Besides, the greater the participation of public 
health the lower the growth rate of health spending. Meanwhile, demographic 
dependency generally opposite influences. 
Our paper contains various innovative approaches. Firstly, as far as we are 
concerned, our main contributions to the existing literature consist in analysing 
empirically short-run versus long-run income elasticity of health care, testing for the 
luxury good hypothesis. In doing so, we transmit a distinction on previous 
contributions, as the ones by Newhouse (1977) or Sen (2005), while harmonize recent 
topics in health economics research. Secondly, our findings may help to explain recent 
outcomes by economists, viz, huge health care spending heterogeneity across countries, 
increasing income inelasticity over time along with threshold effect. Thirdly, from a 
policy economic perspective, our paper encourages the debate about implications of 
government’s involvement for the provision of health services, and therefore on the 
sustainability of national health care systems.  
The remainder of the paper is structured as follows. Section II provides an 
overview of the empirical model and a brief description of the data. Section III presents 
the results derived from the model. The final section summarizes and concludes. 
 
I. Empirical model and data 
 
As identified in previous section, the acknowledgeable literature on health economics 
has suggested income and non-income determinants are both important drivers of health 
Page 5 of 39
































































care expenditure. So in a first step, a linear and homogeneous panel data model for 
health expenditure (as dependent variable to be analyzed) based on Newhouse (1977), 
Gerdtham (1992) and Roberts (1999) is specified. In a more formal way, our model 
becomes: 
 
( ) ititit fy εβ,x +=  ,      (1) 
where yit is the natural logarithm of per capita health spending at the tth observation for 
the ith country; f(•) denotes health care expenditure structure; xit is the corresponding 
matrix of explanatory variables; β is a vector of parameters to be estimated. The εit’s are 
random errors assumed to be independent and identically distributed with mean zero 
and variance 2εσ . 
Previously highlighted by other researches, the preliminary estimates of the 
linear panel Equation 1 reveal a number of problems to deal with: i.e. residuals suffer 
from first-order autocorrelation and revealed group-wise heteroscedasticity. So, firstly, 
after initial estimates of the linear one-way fixed effect model, we use a Feasible 
Generalized Least Squares (FGLS) estimator, introducing temporal effects (two-way 
estimation), in order to prevent any possible problem. This procedure allows estimation 
in presence of first order autocorrelation within panels and cross-sectional correlation, 
and heterocedasticity across panels. Then, the general linear model can be expressed as: 
 itiitit εxy +++= tdαβ'
 ,      (2) 
where αi is a country specific effect and td  is a time dummy variable. On a second step, 
we use a dynamic panel data approach. Specifically, the system-GMM estimator 
developed by Arellano and Bover (1995) and Blundell and Bond (1998) is employed. 
The main advantage of system-GMM lies in the fact that unlike within or between 
methods, it uses the estimation in levels and exploits not only the variation in data over 
time but also between countries. Moreover, this methodology sets additional enough 
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criteria that correlations between unobserved fixed effects and explanatory variables are 
constant over time. System-GMM method combines the standard set of equations in 
first differences with suitably lagged levels as instruments. Furthermore, the Arellano-
Bond methodology tests for the hypothesis of absence of serial correlation and the 
standard errors of the estimates are robust to heteroscedasticity.  
A general dynamic panel data in the first order specification from Equation 2 can 
be written as follows: 
 ititiitit
yxy εβ ,
' +++= − αθ 1  .      (3) 
Note we included on the right hand side of Equation 3 the lagged dependent variable, in 
order to capture the inertia of health care expenditure, and to determine if there exist an 
“anchorage effect”, that is, if the spending on a year is conditioned by the previous one 
or not. We now have in the equation the entire history, so any impact of xit represents 
the effect of new information (Greene, 2012). This paper aims to test whether health 
expenditure is a necessary or a luxury good. Therefore, after direct estimation of 
Equations 2 and 3, β income coefficient will give short-run elasticity, while the long-run 
elasticity would be β income coefficient in the long-term model. This parameter is not 
directly estimable, so to calculate it the estimated coefficients of the short-term model 
(3) are used. Then, long-run elasticity can be recovered by using:  







                                                                 
(4) 
This paper also focuses on both possible breaks and convergence in health care 
expenditure between countries. Are there automatic forces that lead to convergence over 
time in per capita health expenditure, or whether the relative position of each country 
tends to stabilize over time? At some risk of oversimplifying, we interpret convergence 
as the possible existence of a tendency towards the reduction over time of health care 
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expenditure differential between countries. This concept of convergence is the so-called 
sigma-convergence, measured by the standard deviation of the logarithm of the variable 
(De la Fuente, 2000). It does not necessary imply to withdraw inequality, but it does 
mean that the distribution will tend to stabilize in the long-run, provided some structural 
characteristics remain unchanged. These questions correspond to the concepts of 
absolute and conditional beta-convergence from the neoclassical growth theory (Barro 
and Sala-i-Martin, 1995). While it is assumed that sample countries converge to the 
same steady state in the former, each country converges to its own steady state in the 
latter. In both cases, the growth rate of health spending will be positively related to the 
distance that separates an economy from its steady state (Nixon, 1999).  
Then, subtracting the lagged dependent variable from both sides of the Equation 
3, the dynamics of the health care expenditure for a general case yields1: 
 ititiitit
yxy ε)(β ,
' +++−+=∆ − t1 d1 αθ  .      (5) 
While unconditional convergence focuses the analysis from Equation 5 on the lagged 
value of health expenditure, conditional convergence also considers income and other 
explanatory variables. Next, we explore the dynamics of these in terms of the impact of 
per capita health care level on the evolution of the relative expenditure of two countries. 
On the one hand, if 1<θ  the coefficient of the lagged variable ( ) 01 <−θ , then growth 
rate of health care falls with the expenditure level and this implies that per capita health 
care expenditure tends to converge across countries. On the other hand, if 1>θ  it 
follows that ( ) 01 >−θ , so the growth rate of health care increases with the level of 
expenditure, and per capita health care expenditure across countries increases without 
bounce.  
                                                
1 Again, we use a FGLS estimator introducing temporal effects. 
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Basic data used in this analysis are taken from the OECD Health Data (2012), 
the main and largest available source of information to compare health care systems2. 
Empirical results are based on a balanced panel dataset for fourteen countries over the 
period 1971-2009: Australia, Austria, Canada, Finland, Iceland, Ireland, Japan, New 
Zealand, Norway, Portugal, Spain, Sweden, United Kingdom and the United States. The 
benefits of using a balanced panel data set consist in that it allows doing the analysis of 
stationarity of the variables. Most of the tests require that the panels be strongly 
balanced. 
In this paper, we consider as dependent variable the log of per capita health care 
expenditure (expenditure), expressed in $US purchasing power parities (PPP). The list 
of explanatory variables is based on data availability for a balanced panel and they were 
used by knowledgeable scholars (i.e.: Baltagui and Moscone, 2010)3. It includes first 
the lagged dependent variable (expendituret-1) to account for the anchorage effect. 
Second, the log of PPP per capita GDP (income) to analyze the income elasticity of 
health care expenditure. As shown in Fig. 1, similar increases in health expenditure 
could be observed through our country sample. Third, a ratio of demographic 
dependency (dependency) to capture the impact that the proportion of children and 
elderly have on health expenditure
4
. It is expected that young and old people use more 
health care services than working age population. Hence, Alemayehu and Warner 
(2004) estimate the magnitude and age distribution of lifetime health care expenditures; 
                                                
2 OECD Health Data allows doing benchmarking and international comparisons of different health 
systems. Additionally both, its frequency (renewable annually) and that it is used in a wide range of 
academic papers, support the reliability of its utilisation. 
3 These are some of the reasons for using these explanatory variables despite other (i.e.: lifestyles or 
supply side variables) in our model. 
4 By definition, the dependency ratio is the relationship between the age population potentially dependent 
between the potentially active age population. There are three main ways to calculate it: i) “total 
dependency ratio” (defined as the population aged 0-14 and the population aged over 65 divided by the 
working age population), which is considered in this paper; ii) “dependency ratio of young” (defined as 
the population aged 0-14 divided by the working age population); and iii) “dependency ratio of older” 
(defined as the population aged over 65 divided by the working age population). 
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in this regard, Jones (2004) reflects the fact that people at a given level of live 
expectancy suffer from more severe, and costly, medical problems. Four, the percentage 
of public health care expenditure over the total (public share) that stands for health 
policies5. Could public and private choices on health care affect total health care 
expenditures? Newhouse (1992) speculates that the spread of insurance has steadily 
reduced price for consumer and so driven up demand for medical services. Finally a 
temporal trend is included, in order to proxy for unobserved factors linked to 
technology (including new health technologies) and to check for the sensitivity of the 
results to specification problems (technology). In this respect, Newhouse (1992) points 
out that technological change means not only new types of physical capital, but also 
new procedures; that is what he calls “the march of science and the increased 
capabilities of medicine”. Table 2 presents the details concerning the definitions and 
sources of the variables. 
[Insert Fig. 1] 




In this section we present the results from the estimation of the panel data models, 
controlling for various periods of time and different samples of countries, although 
before we proceed to perform some preliminary tests. Given that our empirical study is 
based on a time-series cross-country panel data, we first analyze all variables within 
                                                
5 Countries can choose different types of funding: public, private, or a combination of both. Considering 
that the degree of health decentralization of each country is linked to the political constraints and with the 
type of model (Social Security or National Health System) valid in each case, it should be noted that the 
greater degree of decentralization takes place in essentially private models. Then, depending on whom got 
health powers, resources will be got by different ways, and may be taxes will be one of the most 
important ways to slow the growth of national health expenditures (Baicker and Skinner, 2011). 
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Equations 2 and 3 to ensure that there aren’t spurious regressions in our estimates. With 
this aim, various unit root tests for panel data that consider non-stationary series under 
the null hypothesis are carried out. Firstly, we perform first generation of panel unit root 
tests (which do not take into account cross-country dependence). In this regard, Levin-
Lin-Chu (2002), and Im-Pesharan-Shin (2003) on the annual data indicate all variables 
were stationary (public share is the exception). However, a common feature of these 
econometric tests is that they suffer from loss of power when individual specific trends 
are included (Baltagi, 2008). So we carry out the Breitung (2000) test that indicates the 
hypothesis that all variables are unit root is never rejected. 
Secondly, Pesaran (2007) second generation CIPS test (which assumes cross-
section dependence) are reported in Table 3. We present results for lag orders p = 0, 1, 2 
and 3, finding that in most cases variables are nonstationary. We then apply panel 
cointegration tests due to Westerlund (2007), for fourteen series and three covariates. 
Tests reveal the null cannot be rejected at conventional levels6. To sum up, the general 
picture emerging from this strand of hypothesis tests supports the argument for a 
balanced relationship between variables in the long-run, which guarantee for the stable 
equilibrium of the model. It is known that when the series are integrated of the same 
order, they are cointegrated. 
 [Insert Table 3] 
 
Elasticity across countries 
 
We now examine the effect of income and other explanatory variables on health 
expenditure, using OECD data for fourteen countries over the period 1971-2009. Table 
                                                
6 Pt=-9.90 and Pa=-26.35 support the null that the whole panel is cointegrated, whereas Gt=-3.03 and 
Ga=-31.34 also support that at least one of the panel units presents cointegration.  
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4 contains estimation results based on the FGLS estimates from Equation 2, which are 
highly significant with expected signs in most of the explanatory variables. Income 
elasticity of health expenditure around 0.9 suggests health should be classified as a 
necessary good7 although it should be considered with caution in column (iii). These 
results are robust to the inclusion of other variables. On the one hand, the coefficient on 
the dependency ratio is statistically significant and exerts a positive influence on health 
care expenditure. It is expected that young and old people use more health care services 
than working age population. In fact, both variables have been separately identified by 
the literature as having a role in determining health care expenditures (Baltagi and 
Moscone, 2010). On the other hand, the estimated coefficient on public share is also 
significant with a negative sing. That is, countries with higher share of public 
expenditures should have lower per capita health spending. It should be noted, however, 
that Baltagi and Moscone (2010) obtain coefficients are not statistically significant. 
[Insert Table 4] 
Table 5 reports the estimates from the dynamic panel data Equation 3. We 
present results for both, without and with technical progress, in Panels A and B 
respectively. Our findings support the null that health care is a necessity good in the 
short-run, as income elasticity around 0.2 is largely smaller than in the linear model. 
However, the long-run income elasticity from Equation 4 grows sharply and differs 
between panels. Note when the technology progress is omitted (Panel A) coefficient on 
long-run elasticity exceeds the unity, and so health care seems to be a luxury good. 
Otherwise, it remains smaller than unit and health care should be classified as a 
necessary good. Note, the 1.0 rule has limitations, especially when elasticities of 0.2 and 
0.9 are both classified as “necessities”; these numbers are economically and statistically 
                                                
7 Confidence interval at 95% ranges from 0.83 to 1.06. So, if the classification rule is based upon 
comparison to 1.0, statistically strictly the statement could be incorrect. 
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quite different. Both dependency and public share variables are insignificant, and these 
findings accord with previous studies on the OECD countries (Baltagi and Moscone, 
2010). The estimated coefficient on the technology imply a significant positive effect 
(Panel B), which correspond to the impact of technical progress on health care 
expenditure over years. It is also noteworthy that lagged dependent variable is always 
positive and significant. Coefficient on the lagged dependent variable is less than one in 
absolute terms to guarantee the stability of the model. So a year’s health expenditure is 
conditioned at 80% by the one from previous year, despite the presence of explanatory 
variables that represent the effect of new information. This confirms the existence of 
anchorage effect, which means that health expenditure is likely to change in a slowly 
way over the years. In sum, the estimated short-run and long-run elasticities are 
correctly signed in our preferred specification (iii). Furthermore, both the size and the 
significance are remarkable stable in all of the alternative specifications. 
[Insert Table 5] 
Now we briefly discuss the robustness of the results presented above. 
Concretely, we check the sensitivity of the estimates to income and health spending 
heterogeneity in the sample of OECD countries used in our empirical analysis, and also 
to alternative definitions of the sample time. Economic and social heterogeneity across 
countries, despite the ongoing process of global integration, was far from being 
negligible in the period under analysis (López-Bazo et al., 2004). The empirical model 
previously estimated imposes common effects for all the countries in the sample.  
Firstly, we find out about health care differences over time. As shown by 
Carrion-i-Silvestre (2005), the debate about health care expenditure should be addressed 
taking into account structural breaks, if not the estimation of the parameters could be 
biased. Thus, we initially analyze the existence of possible trend breaks for per capita 
Page 13 of 39
































































health expenditure, over the period under analysis. Based on recent papers focused on 
testing for structural breaks in panel data models (i.e.: Liu et al., 2011) —and from a 
graphic outlook in order to homogenize the evolution for the 14 countries—, we split 
the sample time into four subperiods: 1971-1975, 1976-1991, 1992-2001 and 2002-
2009 (Fig. A.1 and Table A.1 in the Appendix)8. Afterwards, to give greater statistical 
reliability to the estimates, we only consider two long periods: 1971-1990 and 1991-
2009. Table 6 reports the results for income elasticity of health expenditure when 
performing our preferred specification (iii). This is the most complete, and therefore the 
sensitivity analysis is focused on it. There, we primary reproduce equation (iii) from 
Table 5. We found, first, the smaller the sample period, the greater the elasticity; and 
second, when taking into account technical progress, elasticity seems to be somewhat 
higher in the former period (1971-1990) than in the latter one (1991-2009)9.  
Secondly, we deal with heterogeneity across countries. As noted above in the 
empirical model and data section, in specifying the regression models (2)-(3) we 
assumed that its specifications applied to all the observations. This is likely not true for 
some of the countries in our sample, suggesting possible omitted variable bias in the 
estimation results discussed above. To test for the significance of these bias, we split the 
sample of countries into two groups based on a cluster analysis for the initial 
observations of health care expenditure and income (that is, for year 1971). The upper-
group (higher initial levels of expenditure and income) consist of: Australia, Austria, 
Canada, Finland, Iceland, New Zealand, Sweden, United Kingdom and the United 
States. Meanwhile, the lower-group (lower initial levels of expenditure and income) 
consist of: Ireland, Japan, Norway, Portugal and Spain. Based on the estimates, Table 6 
reports the average income elasticity of per capita health care expenditure, which seems 
                                                
8 This type of subdivisions is common in growth processes for Western economies. 
9 It should be noted that estimates take into account all the regressors, which vary across the estimations. 
Then, it could explain for instance that both sub-sample estimates are higher than in the complete one. 
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to be higher in the upper-economies. Here, when technical progress is included, the 
estimated coefficient on the average long-run elasticity is about unit, compared with an 
average elasticity for the lower-countries of 0.62. So, long-term elasticity for a lower-
country is up to 40% less than for an upper-one.  That is, spending on health care seems 
to be a need among the lower-countries and a luxury in the upper-group. Then, this may 
indicate the existence of a threshold effect, from which income elasticity increases. 
Average elasticities of this size are plausible on a priori grounds, i.e.: OECD (2011) 
supports richer countries spend more in health goods than the poorer ones. 
[Insert Table 6] 
 
Dynamics of health care expenditure 
 
One approach to assess stability is to study whether health care elasticity has changed as 
time goes on. Firstly, starting with a sample of 15 years from 1971 to 1985, Equation 3 
is estimated recursively by adding one extra observation at a time up to 2009. Fig. 2 
plots the results from the recursive estimates for the full sample observations. When 
assuming non-technical progress, long-term elasticity does not show any trend, and its 
values seem to converge to 1.1. Short-term elasticity initially presents a downward trend 
though its values are very close to a quarter since 1991, and these results agree with 
FGLS estimates. However, in the more likely scenario of technical progress, elasticity 
shows decreasing trends in both the short- and long-term, even below one in the long-
run. 
[Insert Fig. 2] 
Secondly, should the downward trend for the elasticity observed in Fig. 3, when 
assuming technical progress, be interpreted as evidence towards a greater concern in 
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health care? There are several reasons that could be responsible for the downward trend. 
First, as the sample size time increases from 15 to 39 observations elasticity converges 
to the long-run values. Second, the long-run elasticity from Equation 4 falls because the 
coefficient on income (numerator of the statistic) is reduced over time, while the 
coefficient on the lagged variable (in the denominator) remains broadly stable. Third, 
drops of the coefficient on income occurred primarily among lower-countries whereas it 
was less dramatic in initially upper-countries, if any. 
[Insert Fig. 3] 
Thirdly, the specifications discussed above focus on income and do not include a 
variable to represent the scope of less developed countries to catch-up to the health care 
levels prevailing in the industrial countries. To this end, we carry out two approaches 
rooted on the traditional concept of economic convergence from the neoclassical growth 
theory (Barro and Sala-i-Martin, 1995). They were recently considered for health care 
expenditure in Nixon (1999), Kerem et al. (2008), Wang (2009) or Leiter and Theurl 
(2012). Fig. 4 provides evidence to support sigma-convergence. The level of inequality 
fell sharply early years, was stabilized after the second half of the 70s, and continued to 
fall gently into the 90s and 2000. Over the period as a whole the statistic falls by 
approximately two thirds, from 0.10 in 1971 to 0.03 in 2009.  
[Insert Fig. 4] 
On a second step we conducted the analysis for beta-convergence from Equation 
5, in which the dependent variable is the growth rate of per capita health care 
expenditure. Table 7 shows estimates for unconditional convergence regressions in the 
first column, and conditioning for income and other explanatory variables in successive 
columns. In the absence of the conditioning variables for the full set of observations, the 
rate of convergence was estimated to be the traditional 2% per year. Fig. 5 plots the 
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inverse relation between the average growth rate from 1971 to 2009 vs. health 
expenditure in 1971 (initial year). It indicates that health care spending tends to grow 
faster between initially lower-economies, though the process of convergence is very 
slow. Nonetheless, it is interesting to note that when controlling for possible differences 
across national steady state the rate of convergence rose to 9%, and countries converged 
rapidly to the same spending pattern. Another interesting finding is that the coefficient 
on the share of public health expenditure becomes negative and significant at 
conventional levels. Indeed, the coefficient on income is significantly positive in all 
specifications.  
 [Insert Fig. 5] 
Table 7 also deals with convergence across samples of countries. To check for 
different patterns of convergence, we used the two groups of countries previously 
defined, that is, the lower- and upper-groups of countries and estimate the counterpart 
of Equation 5. Perhaps not surprisingly, it should be stressed how estimates show 
marked instability over the period 1971-2009. On the one hand, the rate of convergence 
ranges from 9%, in the upper-group, to 13% for the lower-one. On the other, 
dependency ratio becomes significant positive for the latter, but not for the former. This 
finding is likely due to ageing population of countries like Japan, Portugal and Spain. 
Finally, the estimated coefficient on public share for the period 1991-2009 reflects the 
tendency of the originally lower-countries to develop public health systems, and 
therefore to experience relatively lower growth of health care spending. Note the 
coefficient on public health care expenditure for lower-countries over the period 1991-
2009 is near four folds the one for upper-countries (i.e. -0.009 vs. -0.34). Therefore, 
growth rates pick up changes in relative social and institutional issues. 
[Insert Table 7] 
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III. Conclusions  
 
The results found in this study for a sample of 14 OECD countries over the period 
1971-2009 support the hypothesis that health care is a necessity in the short-run, though 
it cannot be strongly rejected to be a luxury good in the long-run. In this respect, the 
evidence put forward reveals substantial territorial variations in the effect of income and 
socioeconomic characteristics, when controlling by initial levels of both per capita 
income and health expenditure. In particular, we find that long-term income elasticity 
across the lower-countries is, on average, up to 40% less than the obtained between the 
upper-ones. These findings ultimately imply that spending on health care should always 
be a need for lower-countries, even in the long-term, and thus the need of covering costs 
of living becomes more complex the higher the income (threshold effect). 
Also, our results indicate that about 80% of a year’s health expenditure is 
conditioned by the previous one despite the presence of other explanatory variables. The 
anchorage effect might be behind the features observed, and already reported in the 
recent literature, about the sustainability of national health care systems. This would be 
due, everything else being equal, the fact that national health expenditures are likely to 
change in a very slowly way over the years.  
Both, initial health expenditure-income clusters and temporal breakdown, 
suggest that income elasticity should lead that national standards of health care 
spending converge in the long-run. However, other socioeconomic characteristics as the 
forms —public or private— of supply health services reflect the tendency of the 
originally lower-countries to develop public health systems, and therefore to experience 
significant lower growth of health care spending than the upper-ones. Demographic 
dependency generally opposite influences. 
Page 18 of 39
































































From a policy economic perspective, rising trends in health expenditure had 
concerned about the sustainability of national health care systems. However, our results 
confirm that nowadays same health policies can have different effects, depending on the 
framework in which it is implemented. For example, public health expenditure cuts 
could increase private health expenditure (related with income) with an indeterminate 
effect on total health expenditure. The evidence for a diverse sample of countries 
suggests that when controlling for the baseline, public participation might be significant 
for limiting the growth of health spending. Similarly, there is also evidence that greater 
health expenditures do not unavoidably reverse in health outputs improvements. On the 
one hand, spending on health care seems to be increasingly decoupled from income 
changes between some countries. On the other, if cuts are in necessary investments 
there will be significant health spending increases over the long-run (OECD, 2010 and 
2012).  
Finally, it is worth stressing, from an economic point of view, that technological 
innovation, while enabling extraordinary achievements in improving health, exerts 
additional pressure on health spending by introducing drugs and high-cost techniques in 
the OECD countries. Technological change has significantly shifted out the frontier 
medical condition that can be treated (Jones, 2004; García and Manrique, 2012). 
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Figures and Tables 
 
 
Table 1. A summary survey of previous studies on national health care expenditure 
 
REFERENCE CROSS-SECTIONS TIME-PERIOD METHODOLOGY 
INCOME  
ELASTICITY 
Newhouse (1977) 13 developed countries 1970 Cross section. 1.15-1.31 
Leu (1986) 19   OECD  countries 1974 Cross section. 1.18-1.36 
Parkin et al. (1987) 18 OECD countries 1980 Cross section. 1.12-1.18 
Gerdtham et al. (1992 
a and b) 
19   OECD  countries 1987 Cross section. 1.33 
Hitiris (1997) 10 OECD countries 1960-1991 Panel Data. 1.14-1.17 
Gerdtham et al. 
(1998) 
22 OECD countries 1970-1991 Panel Data. 0.74 





Sen (2005)  
 











Baltagi and Moscone 
(2010) 
20 OECD countries 1971-2004 Panel data. 0.45-0.90 
Mehrara et al. (2010) 16 OECD countries 1993-2007 Panel data. 2.59 





Hui-Kuang et al. 
(2011) 
25 countries: Taiwan and 
24 OECD countries 
1992-2007 Quantile regressions. 1.20-1.47 
Woodward and Wang 
(2012) 
United States 1960-2008 Time series. 1.39 
Farag et al. (2012) 
173 developing and 
developed countries 
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log of per capita GDP
 
Notes: Australia(aus), Austria(aust), Canada(c), Finland(f), Iceland(ice), Ireland(ire), Japan(j), New 
Zealand(nz), Norway(n), Portugal(p), Spain(sp), Sweden(sw), United Kingdom(uk) and the United 
States(us). Abbreviations of the countries in lowercase letters refer to data for 1971, while those in capital 
letters are for the year 2009.   
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Table 2. Variables and data sources 
 
Variable Definition Data Source 
expenditure 
Per capita total health care expenditure. Expressed in $US 
Purchasing Power Parities (PPP) and natural logarithms. 
OECD Health Data (2012). 
   
income 
Per capita Gross Domestic Product. Expressed in $US PPP 
and natural logarithms. 




Dependency ratio defined as the population aged 0-14 and 
the population aged over 65 divided by the working age 
population. 
Authors’ elaboration based in  
OECD Health Data (2012). 
 
   
public share 
Public health care expenditure as percentage of total health 
expenditures. 
OECD Health Data (2012). 
   
technology 
A temporal trend, in order to proxy for unobserved factors 



































Page 27 of 39




































































number of lags 
0 1 2 3 
expenditure -1.97  -1.91  -1.99  -2.13 * 
income -1.49  -1.90  -1.83  -1.69  

















INTERCEPT and TREND 
number of lags 







 -2.42  
income -2.12  -2.66 * -2.30  -2.07  
dependency -1.20  -3.16 *** -2.79 ** -2.38  
public share -2.81 ** -2.59  -2.72 ** -2.76 ** 
 
Notes:  Null hypothesis CIPS: series are I(1).  
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Table 4. Estimation of the health care expenditure from the linear model 
Dependent variable: expenditure 
 
Variable / Specification  (i) (ii) (iii) 
income 
0.87 *** 0.86 *** 0.94 *** 
(0.06)  (0.06)  (0.06)  
dependency 
  0.44 ** 0.53 ** 
  (0.23)  (0.22)  
public share 
    -0.32 *** 
    (0.08)  
Wald chi2 8039.84 7808.31 8441.26 
Prob > chi2    0.00 0.00 0.00 
AR(1) coefficient 0.92 0.92 0.91 
 
Notes:  Standard errors are reported in brackets. Number of observations: 546.   
 ***, **, and * denote significant at 1%, 5%, and 10%. 
 Coefficient on income yields the short-run elasticity. 
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Table 5. Estimation of the health care expenditure from the dynamic model 
Dependent variable: expenditure 
 
Variable / Specification 
PANEL A  PANEL B  
(i) (ii) (iii) (i) (ii) (iii) 
expendituret-1 
0.83 *** 0.82 *** 0.82 *** 0.80 *** 0.80 *** 0.80 *** 
(0.02)  (0.02)  (0.03)  (0.02)  (0.02)  (0.02)  
income 
0.18 *** 0.20 *** 0.20 *** 0.17 *** 0.17 *** 0.18 *** 
(0.03)  (0.03)  (0.03)  (0.04)  (0.05)  (0.05)  
dependency 
   
0.13  0.13  
   
0.04  0.02  
(0.10)  (0.10)  (0.11)  (0.11)  
public share 
   
   0.01     
   
0.06  
   (0.10)     (0.10)  
technology (x 10) 
      
0.03 ** 0.03 ** 0.03 ** 
(0.00)  (0.00)  (0.00)  














(0.04)  (0.05)  (0.05)  (0.12)  (0.14)  (0.14)  
Arellano-Bond test for AR(1) in first differences  -2.58  -2.56  -2.56  -2.56  -2.56  -2.56  
p-value 0.01  0.01  0.01  0.01  0.01  0.01  
Arellano-Bond test for AR(2) in first differences -2.19  -2.19  -2.20  -2.20  -2.20  -2.17  
p-value 0.03  0.03  0.03  0.03  0.03  0.03  
 
Notes: Robust standard errors are reported in brackets. aStandard errors calculated from Equation 4 using the delta method. ***, **, and * denote significant at 1%, 5%, and 
10%. Number of observations: 532. Coefficient on income yields the short-run elasticity.  
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Table 6. Sensitivity to alternative specifications 
Dependent variable: expenditure 
 
    Short-run elasticity Long-run elasticity
a 
Linear PANEL A PANEL B PANEL A PANEL B 
Full set of sample countries 1971-2009 
0.94 *** 0.20 *** 0.18 *** 1.12 *** 0.87 *** 
(0.06)  (0.03)  (0.05)  (0.05)  (0.14)  
Subperiod  of time 
1971-1990 
1.24 *** 0.30 *** 0.47 *** 1.21 *** 1.55 *** 
(0.07)  (0.07)  (0.07)  (0.08)  (0.14)  
1991-2009 
1.03 *** 0.29 *** 0.29 *** 1.41 *** 1.36 *** 
(0.07)  (0.06)  (0.07)  (0.05)  (0.27)  













(0.09)  (0.06)  (0.07)  (0.08)  (0.19)  
Lower 
0.86 *** 0.16 *** 0.12 *** 1.06 *** 0.62 *** 
(0.09)  (0.03)  (0.03)  (0.07)  (0.07)  
 
Notes: Upper-group (higher health expenditure and income initial levels): Australia, Austria, Canada, Finland, Iceland, New Zealand, Sweden, UK and US; lower-
group (lower health expenditure and income initial levels): Ireland, Japan, Norway, Portugal and Spain. Robust standard errors are reported in brackets. aStandard 
errors calculated from Equation 4 using the delta method. ***, **, and * denote significant at 1%, 5%, and 10%. Panel A, when the technology variable is omitted, 
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1985 1988 1991 1994 1997 2000 2003 2006 2009
Short-run Long-run Short-run with TP Long-run with TP
 
  
Notes: Short- and long-run elasticity without technical progress, left scale; short- and long-run elasticity 
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Fig. 3. Recursive estimates of the income elasticity for two clusters of countries 

















1985 1988 1991 1994 1997 2000 2003 2006 2009
Upper long-run Upper short-run Lower long-run Lower short-run
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log of per capita health expenditure in  1971
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Table 7. Estimation of the growth equation with sensitivity to alternative specifications 
Dependent variable: ∆ expenditure 
 
Variable 
Full set of sample countries 
1971-2009 1971-1990 1991-2009 
expendituret-1 -0.02 
*** -0.07 *** -0.07 *** -0.09 *** -0.02 *** -0.08 *** -0.08 *** -0.09 *** -0.01 *** -0.05 *** -0.05 *** -0.10 *** 



















dependency      0.01  0.06       -0.01  0.02      0.03  0.13 
**
 
public share          -0.09 
***
          -0.06  
***







Upper-group sample countries 
1971-2009 1971-1990 1991-2009 
expendituret-1 -0.01  -0.08 
*** -0.08 *** -0.09 *** -0.00  -0.08 *** -0.09 *** -0.09 *** -0.00  -0.06 *** -0.06 *** -0.08 *** 
income   0.19 *** 0.20 *** 0.19 ***   0.19 *** 0.20 *** 0.19 ***   0.16 *** 0.16 *** 0.15 *** 
dependency      -0.07  -0.04       -0.15 * -0.12      0.04  0.11  





Lower-group sample countries 
1971-2009 1971-1990 1991-2009 
expendituret-1 -0.02 
*** -0.11 *** -0.14 *** -0.13 *** -0.03 * -0.13 *** -0.20 *** -0.21 *** -0.01  -0.09 *** -0.11 *** -0.06 ** 
income   0.12 *** 0.16 *** 0.17 ***   0.14 *** 0.28 *** 0.34 ***   0.10 *** 0.11 *** 0.13 *** 
dependency      0.11 ** 0.15 ***      0.23 *** 0.34 ***     0.15 * 0.20 *** 
public share          -0.07           -0.10            -0.34  *** 
 
Notes: Upper-group (higher health expenditure and income initial levels): Australia, Austria, Canada, Finland, Iceland, New Zealand, Sweden, UK and US; lower-group 
(lower health expenditure and income initial levels): Ireland, Japan, Norway, Portugal and Spain. ***, **, and * denote significant at 1%, 5%, and 10%. 
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Table A.1. Determinants of health care expenditure: Econometric estimates of subperiods for specification (iii).  
Dependent variable: expenditure 
 
     Short-run elasticity Long-run elasticity
a 
     Linear PANEL A PANEL B PANEL A PANEL B 
 Full set of observations 1971-2009 
 
0.94 *** 0.20 *** 0.18 *** 1.12 *** 0.87 *** 
(0.06)  (0.03)  (0.05)  (0.05)  (0.14)  





 0.58 *** 0.44  2.46 *** 1.95  





 0.29 *** 0.33 *** 1.09 *** 1.22  











 1.43  
(0.08)  (0.14)  (0.12)  (0.07)  (0.27)  
2002-2009 
 
1.06 *** 0.20 *** 0.19 *** 1.18 *** 1.05  
(0.07)  (0.06)  (0.06)  (0.12)  (0.38)  
 
Notes: Robust standard errors are reported in brackets. aStandard errors calculated from Equation 4 using the delta method. ***, **, and * denote significant at 1%, 5%, and 




Page 39 of 39
Editorial Office, Dept of Economics, Warwick University, Coventry CV4 7AL, UK
Submitted Manuscript
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
